Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The procedure described by CPT® Code 89290 involves the biopsy of oocyte polar bodies or embryo blastomeres using microtechniques specifically for pre-implantation genetic diagnosis (PGD). This procedure is crucial for patients who are known carriers of specific genetic diseases, as it allows for the identification of genetically normal oocytes or embryos prior to implantation. The process begins with a microscopic examination of the oocyte to assess its maturity if the biopsy is performed on an oocyte. In cases where the biopsy is conducted on an embryo, the viability of the embryo is also evaluated. During the procedure, the oocyte or embryo is carefully held in place with a holding pipette while being observed under a microscope. A small incision is made in the oocyte or embryo using either a mechanical or enzymatic method. Following this, a biopsy pipette is utilized to extract one or two polar bodies or blastomeres, which are then sent for separate genetic analysis. This code is applicable when the biopsy involves five or fewer oocytes or embryos, while a different code, CPT® Code 89291, is designated for procedures involving more than five oocytes or embryos.
© Copyright 2026 Coding Ahead. All rights reserved.
The procedure coded as CPT® 89290 is indicated for patients who are known carriers of certain genetic diseases. The primary purpose of this biopsy is to identify genetically normal oocytes or embryos, which is essential for couples undergoing in vitro fertilization (IVF) who wish to minimize the risk of passing on genetic disorders to their offspring.
The procedure involves several critical steps to ensure the successful biopsy of oocyte polar bodies or embryo blastomeres.
Post-procedure care typically involves monitoring the patient for any immediate complications following the biopsy. The extracted polar bodies or blastomeres are sent for genetic analysis, and the results will guide the selection of embryos for implantation. Patients may be advised on the next steps in their fertility treatment plan based on the outcomes of the genetic testing. It is essential for healthcare providers to communicate the results effectively and discuss the implications for future pregnancies.
| Short Descr | BIOPSY OOCYTE POLAR BODY <=5 | Medium Descr | BX OOCYTE POLR BDY/EMBRY BLST MICROTQ <= 5 EMBRY | Long Descr | Biopsy, oocyte polar body or embryo blastomere, microtechnique (for pre-implantation genetic diagnosis); less than or equal to 5 embryos | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | STV-Packaged Codes | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 | CCS Clinical Classification | 206 - Microscopic examination (bacterial smear, culture, toxicology) |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2024-01-01 | Changed | Short and Medium Descriptions changed. |
| 2013-01-01 | Changed | Medium Descriptor changed. |
| 2011-01-01 | Changed | Short description changed. |
| 2004-01-01 | Added | First appearance in code book in 2004. |
Get instant expert-level medical coding assistance.